Area of research
Complementary and alternative medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cardiovascular and exercise physiology, Hormonal and reproductive studies, Cardiovascular Function and Risk Factors, and Nutrition and Health in Aging.
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189
FP13.04 KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC
389P Updated analysis from the KEYNOTE-042 China study: 1L pembrolizumab (pembro) vs chemotherapy (chemo) in Chinese patients (pts) with advanced NSCLC with PD-L1 TPS ≥1%